Yusuf Henriques, MPH


Co-Founder, Chief Executive Officer


Yusuf Henriques is a disabled veteran and a former Combat Medic in the U.S. Army. During his military career, he worked in the critical care areas such as Burn Units, ICUs and Trauma/Emergency Rooms. After his medical retirement, he earned a Bachelor’s Degree in Biochemistry from Howard University. 


Yusuf worked at the Food and Drug Administration (FDA) as an Interdisciplinary Scientist conducting reviews for new drug/biologics and medical device approvals.

After the FDA, he worked as a Senior Research Health Scientist for Outpatient Psychiatry at the VA Medical Center in Bronx NY. Simultaneously, he was a Research Associate at Icahn School of Medicine at Mount Sinai where he was responsible for managing a joint VA and military multi-center clinical trial research portfolio for PTSD and traumatic brain injury.

Charles Cathlin, MPH


Co-Founder, Chief Operating Officer


Charles Cathlin is a former Chief of Staff of the Defense and Veterans Brain injury Center (DVBIC) where he provided operational and strategic leadership to support traumatic brain injury clinical research programs across 22 DoD and VA facilities. Prior to this assignment, he served at the FDA/Center for Device and Radiological Health as Chief of the Radiology, Anesthesiology, and Neurology Devices Branch.


He received his BS in Civil and Environmental Engineering from the U.S Air Force Academy and his Master of Public Health from the Uniformed Services University of the Health Sciences (USUHS). He is also a graduate of the Johns Hopkins University, Carey Business School Innovate program, established to train biotech entrepreneurs.


Charles retired as a Captain (O-6) in May 2018 after completing twenty-three years in uniform between the Air Force and the Public Health Service, earning decorations for his leadership while deployed to the Middle East, Albania, Mozambique, and New York City (9/11).

Tshaka Cunningham, PhD


Co-Founder, Chief Scientific Officer


Dr. Tshaka Cunningham previously served as the Scientific Program Manager for the Aging and Neurodegenerative Diseases Rehabilitation Research Program at the U.S. Department of Veterans Affairs within the Veterans Health Administration’s Office of Research & Development (VHA ORD).


He earned a BA degree in Molecular Biology from Princeton University in New Jersey. He then worked as a research scientist at Bristol-Myers Squibb Pharmaceuticals Inc., where he developed biological screening assays to identify drugs for the treatment of cardiovascular diseases. He earned his doctoral degree in molecular biology, with a focus on virology, from Rockefeller University in New York. He completed his postdoctoral training in immunology and tumour immunotherapy at the Pasteur Institute in Paris, France, and at the National Institutes of Health in Bethesda, MD. 


Tshaka served as a subject matter expert for VA’s Genomic Medicine Implementation Program (GMIP) and convened the Million Veteran Program Diversity Working Group.